Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MIST

Why Is Milestone Pharmaceuticals Stock Plunging On Friday?

Milestone Pharmaceuticals Inc. (NASDAQ:MIST) moved closer to potential FDA approval for its Cardamyst (etripamil) nasal spray, an investigational therapy for paroxysmal supraventricular tachycardia (PSVT), as the U.S. Food and Drug Administration (FDA) accepted the company’s response to prior issues.

Benzinga

New on HBO and Max in February 2025 — all the new shows and movies to watch

There's plenty to check out on HBO and Max this February, and we've rounded up our favorite picks.

Tom’s Guide

Unrivaled Week 2 storylines to watch, including what’s next for Angel Reese

Here's what you need to know about Unrivaled Week 2.

USA Today Sports Media Group

From analysis to the latest developments in health,
read the most diverse news in one place.

"Barmy night in Bracknell" promised as Spriggan Mist joined by EBB, Haze and Kindred Spirit for Four Play Progfest III

Bracknell prog all dayer Four Play Progfest III returns for the frst time since 2017, taking place on November 9

Louder

Former Met officer ‘shocked’ to realise she was still Wayne Couzens’ case officer, hearing told

Former PC Samantha Lee was the officer investigating an allegation of indecent exposure by Wayne Couzens

Evening Standard

Ex-Met constable ‘shocked to realise she was still Wayne Couzens case officer’

Samantha Lee is said to have failed to make the correct inquiries over two incidents when Sarah Everard’s killer exposed himself at a McDonald’s.

The Independent UK

15 years ago, a Stephen King sci-fi classic became his most infamous movie

A single change to the story sparked controversy... and praise. Here's how 'The Mist' redefined one of Stephen King's best stories.

Inverse

Read news from The Economist, FT, and more,
with one subscription

Milestone Pharmaceuticals: Q1 Earnings Insights

Milestone Pharmaceuticals (NASDAQ:MIST) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Benzinga

Milestone Pharmaceuticals: Q4 Earnings Insights

Milestone Pharmaceuticals (NASDAQ:MIST) reported its Q4 earnings results on Thursday, March 24, 2022 at 07:20 AM. Here's what investors need to know about the announcement.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the US Food and Drug Administration

60 stories

Milestone

31 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.